Sell-side & buy-side advisory · U.S. pharmacy sector

The quiet market for exceptional pharmacy assets.

Pharmacy Brokerage Services represents owners and acquirers in the confidential sale, purchase, and recapitalization of specialty, compounding, and independent pharmacy businesses — with the discretion the moment demands.

The practice

A boutique advisory built around a single sector — and a single standard of discretion.

We do one thing: move pharmacy businesses between owners cleanly, confidentially, and at the right value. Buyers and sellers work with the same team from first conversation to close.

01

Sell-side representation

Owner-aligned exits, run end to end. We prepare the business, control the narrative, and take the process to a curated set of qualified buyers — never a public auction.

02

Buy-side mandates

For strategic and financial buyers, we source and secure hard-to-find pharmacy assets — including proprietary opportunities that are never openly marketed.

03

Valuation & deal packaging

Defensible valuation paired with institutional-grade materials — blind teaser, full confidential information memorandum, and a diligence-ready data room.

04

Confidential marketing

Pre-qualified outreach under NDA that surfaces genuine interest while protecting your name, your staff, and your patient relationships until it matters.

The confidential index

Assets come to market quietly.

Live mandates — and the categories we represent. Identifying detail stays redacted until a mutual non-disclosure agreement is in place.

Ref.AssetGeographyStatus
PBS-0417
Turnkey cGMP 503B sterile compounding facility
Southern California
Live · view teaser
PBS-0526
Independent specialty & community pharmacy
Inland Empire, CA
Live · view teaser
PBS-0726
Combination pharmacy · retail, LTC & DME
Greater Los Angeles
Live · view teaser

Mandate types we represent

PBS · —
Specialty pharmacy platform
Undisclosed
Pre-NDA
PBS · —
Independent & retail pharmacy group
Undisclosed
Pre-NDA
PBS · —
Long-term care & closed-door pharmacy
Undisclosed
Pre-NDA
PBS · —
Home infusion & specialty distribution
Undisclosed
Pre-NDA

Full CIM available upon execution of a mutual NDA.

How a mandate comes to market

Five disciplined stages, one confidential process.

01

Valuation & readiness

We establish a defensible range and prepare the business to withstand buyer diligence before anyone sees it.

02

Confidential packaging

A blind teaser and full CIM tell the story compellingly — without exposing your identity.

03

Curated outreach

We approach a short list of qualified strategic and financial buyers under NDA — quietly, never at auction.

04

Diligence & terms

We run the data room, manage competing interest, and negotiate structure to protect value and certainty.

05

Close & transition

We carry the transaction through signing, funding, and a clean operational handoff.

Sectors we cover

Depth where it counts.

We speak the language buyers underwrite — licensure, REMS, payer mix, and the regulatory posture unique to each pharmacy model.

503A / 503B

Sterile & non-sterile compounding

Outsourcing facilities and compounding pharmacies.

Specialty

Specialty pharmacy

Limited-distribution, high-touch therapeutic platforms.

Retail

Independent & retail

Single stores to multi-location independent groups.

LTC

Long-term care & closed-door

Institutional, assisted-living, and correctional service.

Infusion

Home infusion & distribution

Ambulatory infusion and specialty distribution assets.

Why Pharmacy Brokerage Services

Sector fluency and absolute discretion — in the same firm.

Sector specialization

We only do pharmacy. That means we can price the things generalist brokers miss — DEA and state licensure, REMS obligations, 340B exposure, and payer concentration.

Confidential by design

Your name stays protected until an NDA is signed. Discretion isn't an add-on to our process — it is the process.

Institutional-grade materials

Every mandate is packaged to the standard buyers expect: a blind teaser, a complete CIM, and a diligence-ready data room.

Curated buyer access

Direct relationships with the strategic acquirers, platforms, and financial sponsors actively deploying capital into pharmacy today.

Start a confidential conversation

Considering a sale — or a strategic acquisition?

Every conversation begins in confidence. Reach out to discuss a potential mandate, a valuation view, or a specific acquisition target. No obligation, and nothing leaves the room.

Charlie LeBon
Chief Business Development Officer
charlie@pbsmna.com www.pbsmna.com
Please add your name.
Please add a valid email.
Please choose one.
Please add a short message.

Submitting opens a pre-addressed, confidential email to Charlie LeBon. Your message is not stored on this site.